Alliance Pharma Share Price (APH)

0.00 0.00 (0.00%) delayed: 5:03AM BST
Bid price 66.60 Open price 0.00
Ask price 67.00 Prev close 67.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Alliance Pharma share prices, Alliance Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Alliance Pharma Level 2 Data, indepth research tools and investor commentary for Alliance Pharma (APH) and other London Stock Exchange equities.

Alliance Pharma Share Price Chart

Advanced Charts >>

Register now for FREE Alliance Pharma share price charts

Alliance Pharma Share Price Information

Name Alliance Pharma Epic APH
Sector Pharmaceuticals & Biotechnology ISIN GB0031030819
Activites Alliance Pharma plc is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio. Index n/a

Alliance Pharma Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 36.23
Market Capitalisation (£m) 339.98 Gross Gearing (%) 39.56
Shares in issue (m) 515.13 Debt Ratio 26.22
P/E Ratio 10.82 Debt-to-Equity Ratio 0.54
Total dividends per share (p) 1.33 Assets / Equity Ratio 1.65
Dividend Yield (%) 2.08 Price to book value 1.67
Dividend cover (x) 4.44 ROCE (%) 10.29
Earning per share (p) 6.10 EPS Growth (%) 58.44
52 week high / low 102.50 / 56.00 DPS Growth (%) 9.92

Alliance Pharma Director Deals

Dec.Date Type Director Pos No. of Shares
14/02/2017 EXR Peter Butterfield CEO 90,222
14/02/2017 SEXR Peter Butterfield CEO 61,846
23/09/2016 SELL John Dawson NED 3,000,000
05/05/2016 BUY David Cook CH 54,492
05/05/2016 BUY David Cook CH 47,879

More Alliance Pharma Director Deals >>

Alliance Pharma Company News

10:25 05/10/2018

Grant of Options to Directors

RNS Number : 1320D Alliance Pharma PLC 05 October 2018   5 October 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Grant of Options to Directors Alliance Pharma plc (AIM: APH), the international specialty pharmaceutical group, announces that the Board has...

09:53 02/10/2018

Alliance Pharma launches nausea and vomiting treatment in UK

Alliance Pharma, a specialty pharmaceutical company, launched its prescription product for the treatment of nausea and vomiting of pregnancy in the UK on Tuesday. Xonvea, the treatment of nausea and vomiting of pregnancy, was a new licensed medicine available in the UK for women with NVP where...

07:00 02/10/2018

Xonvea launch in the UK

RNS Number : 6061C Alliance Pharma PLC 02 October 2018   For immediate release 2 October 2018   ALLIANCE PHARMA PLC ("Alliance" or the "Group")   Xonvea ® launch in the UK     Alliance Pharma plc  (AIM: APH), the...

More Alliance Pharma Company News >>

Register now for FREE Alliance Pharma company news

Alliance Pharma Share Price Discussions

26 days ago

Alliance Pharma (APH)

anyone into these , they seem to have a very good write up and so I bought some !!! The interims are due Sept 13th worth. watching around that date. See Objective Capital.com or it may be Objective Capital .co.uk Try both

more than 1 year ago

ALLIANCE PHARMA – 2005 Strong Riser (APH)

http://www.hardmanandco.com/Research/Alliance_June2005.pdf Web Site : http://www.alliancepharma.co.uk http://www.hemscott.com/hstoday/Focus_2005/Alliance%20Pharma_1205_2005.htm Hardmans late June 2005 update Fair value at 30p...

Register now for FREE Alliance Pharma share price discussions